Department of Graduate School of Medicine (Cardiology), International University of Health and Welfare, Okawa, Japan.
Omron Heathcare Co., Ltd., Kyoto, Japan.
Hypertens Res. 2024 Feb;47(2):529-532. doi: 10.1038/s41440-023-01510-9. Epub 2023 Nov 28.
In Japan, a hypertension treatment aid application (CureApp Co., Ltd.) with educational content on hypertension was the first in the world to show significant blood pressure (BP) reduction in hypertensive patients in 2021. Omron Healthcare Corporation and I developed the Health data Monitoring System (HMS) without educational content, which allows patients to check their home BP values periodically and allows physicians to check their home BP data before the hospital visit. As a pilot study, nineteen patients with hypertension used HMS for six months. The percentage of patients achieving their antihypertensive goal increased from 16% to 37%. Mean home systolic BP decreased from 138.1 ± 11.8 mmHg to 130.2 ± 7.8 mmHg. The increase in number of home BP measurements was significantly associated with the amount of homed systolic BP reduction in men. In conclusion, HMS without educational content may be an adjunct to hypertension treatment.
在日本，2021 年一款具有高血压教育内容的高血压治疗辅助应用程序（CureApp 株式会社）首次显示出高血压患者的血压显著降低。欧姆龙健康医疗株式会社和我共同开发了没有教育内容的健康数据监测系统（HMS），允许患者定期检查自己的家庭血压值，并允许医生在就诊前检查他们的家庭血压数据。作为一项试点研究，19 名高血压患者使用 HMS 六个月。达到降压目标的患者比例从 16%增加到 37%。家庭收缩压平均值从 138.1±11.8mmHg 降至 130.2±7.8mmHg。家庭血压测量次数的增加与男性家庭收缩压降低量呈显著相关。总之，没有教育内容的 HMS 可能是高血压治疗的辅助手段。
